The Rise of the Private Genome Databases
StartUp Health
151

I just enjoyed a conversation yesterday with a talented biotech innovator who’s focused on the creation of ecosystems somewhat similar to this in order to deliver more quickly novel treatments. His approach incorporates also clinical trial organizations as well as large scale clinical delivery environments. I imagine these genomic players will expand eventually to include the same.

The data silo factor worries me, but as you write, the incentives aren’t aligned well for information sharing (though I understand there are also some novel approaches).

One clap, two clap, three clap, forty?

By clapping more or less, you can signal to us which stories really stand out.